Improvement in β-Cell Secretory Capacity After Human Islet Transplantation According to the CIT07 Protocol
暂无分享,去创建一个
M. Rickels | R. Shlansky-Goldberg | E. L. Luning Prak | Chengyang Liu | A. Naji | M. Kamoun | Allen J. Chiou | C. Barker | S. Soleimanpour | K. Vivek | E. Markmann | Carissa Fuller | C. DALTON-BAKES | Z. Min | Maral Palangian
[1] M. Rickels. Recovery of Endocrine Function After Islet and Pancreas Transplantation , 2012, Current Diabetes Reports.
[2] Nicole A. Turgeon,et al. Improvement in Outcomes of Clinical Islet Transplantation: 1999–2010 , 2012, Diabetes Care.
[3] B. Hering,et al. Potent Induction Immunotherapy Promotes Long‐Term Insulin Independence After Islet Transplantation in Type 1 Diabetes , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[4] S. Paraskevas,et al. Evidence of Endoplasmic Reticulum Stress Mediating Cell Death in Transplanted Human Islets , 2012, Cell transplantation.
[5] M. Rickels,et al. Accumulation of intrahepatic islet amyloid in a nonhuman primate transplant model. , 2012, Endocrinology.
[6] M. Rickels,et al. Hypersensitivity to rabbit antithymocyte globulin in an islet transplant recipient: a case report. , 2011, Transplantation proceedings.
[7] C. Ricordi,et al. Correction of insulin sensitivity and glucose disposal after pancreatic islet transplantation: preliminary results , 2010, Diabetes, obesity & metabolism.
[8] T. Berney,et al. Glucose inhibits angiogenesis of isolated human pancreatic islets. , 2010, Journal of molecular endocrinology.
[9] M. Rickels,et al. HLA Class I Sensitization in Islet Transplant Recipients: Report from the Collaborative Islet Transplant Registry 1 , 2010, Cell transplantation.
[10] T. Berney,et al. Influence of Donor Age on Islet Isolation and Transplantation Outcome , 2010, Transplantation.
[11] B. Hering,et al. Erratum: Prolonged insulin independence after islet allotransplants in recipients with type 1 diabetes(American Journal of Transplantation (2009) 8 (2463-2470) DOI: 10.1111/j.1600-6143.2008.02404.x ) , 2010 .
[12] M. Rickels,et al. {beta}-Cell secretory capacity and demand in recipients of islet, pancreas, and kidney transplants. , 2010, The Journal of clinical endocrinology and metabolism.
[13] A. Shapiro,et al. Insulin-Heparin Infusions Peritransplant Substantially Improve Single-Donor Clinical Islet Transplant Success , 2010, Transplantation.
[14] A Sundin,et al. Positron Emission Tomography in Clinical Islet Transplantation , 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[15] B. Hering,et al. Prolonged Insulin Independence After Islet Allotransplants in Recipients with Type 1 Diabetes , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[16] S. Kahn,et al. An examination of β‐cell function measures and their potential use for estimating β‐cell mass , 2008, Diabetes, obesity & metabolism.
[17] M. Rickels,et al. Acute insulin responses to glucose and arginine as predictors of beta-cell secretory capacity in human islet transplantation. , 2007, Transplantation.
[18] R. Robertson. Estimation of β-Cell Mass by Metabolic Tests , 2007, Diabetes.
[19] M. Rickels,et al. Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity. , 2007, The Journal of clinical endocrinology and metabolism.
[20] Philippe Morel,et al. International trial of the Edmonton protocol for islet transplantation. , 2006, The New England journal of medicine.
[21] B. Hering,et al. Intrahepatic Transplanted Islets in Humans Secrete Insulin in a Coordinate Pulsatile Manner Directly Into the Liver , 2006, Diabetes.
[22] M. Rickels,et al. Insulin sensitivity, glucose effectiveness, and free fatty acid dynamics after human islet transplantation for type 1 diabetes. , 2006, The Journal of clinical endocrinology and metabolism.
[23] B. Hering,et al. Effect of Donor Age on Function of Isolated Human Islets , 2006, Diabetes.
[24] B. Hering,et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. , 2005, JAMA.
[25] T. Berney,et al. Assessment of a Novel Two-Component Enzyme Preparation for Human Islet Isolation and Transplantation , 2005, Transplantation.
[26] G. Elgue,et al. TISSUE FACTOR RELEASED BY THE ENDOCRINE CELLS OF THE ISLETS OF LANGERHANS IS ASSOCIATED WITH A NEGATIVE OUTCOME OF CLINICAL ISLET TRANSPLANTATION , 2004, Diabetes.
[27] T. Berney,et al. Serva collagenase NB1: a new enzyme preparation for human islet isolation. , 2004, Transplantation proceedings.
[28] D. Harlan,et al. Sirolimus-induced interstitial pneumonitis in an islet transplant recipient. , 2003, Diabetes care.
[29] B. Wolf,et al. Insulin Independence Following Isolated Islet Transplantation and Single Islet Infusions , 2003, Annals of surgery.
[30] K. Ekdahl,et al. Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation , 2002, The Lancet.
[31] D. D’Alessio,et al. Impaired beta-cell function, incretin effect, and glucagon suppression in patients with type 1 diabetes who have normal fasting glucose. , 2002, Diabetes.
[32] B. Ahrén,et al. Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine , 1998, Diabetologia.
[33] C. Ricordi,et al. Improved Human Islet Isolation Using a New Enzyme Blend, Liberase , 1997, Diabetes.
[34] D. Finegood,et al. The metabolic impact of rapamycin (sirolimus) in chronic canine islet graft recipients. , 1996, Transplantation.
[35] G. Warnock,et al. Cytotoxic effects of cytokines on human pancreatic islet cells in monolayer culture. , 1990, The Journal of clinical endocrinology and metabolism.
[36] J. Markmann,et al. THE EFFECT OF ISLET CELL CULTURE IN VITRO AT 24°C ON GRAFT SURVIVAL AND MHC ANTIGEN EXPRESSION , 1990 .
[37] P. Lacy,et al. Automated Islet Isolation From Human Pancreas , 1989, Diabetes.
[38] R. Strieter,et al. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxofylline , 1988 .
[39] G. Eisenbarth,et al. Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus. , 1985, Diabetes research.
[40] J. Halter,et al. Adaptation of B and A cell function during prolonged glucose infusion in human subjects. , 1984, The American journal of physiology.
[41] Joan W. Miller,et al. Long-Term Results of Rabbit Antithymocyte Globulin and Basiliximab Induction , 2008 .
[42] R. Robertson. Estimation of beta-cell mass by metabolic tests: necessary, but how sufficient? , 2007, Diabetes.
[43] M. Rickels,et al. HLA sensitization in islet transplantation. , 2006, Clinical transplants.
[44] Michael R. Rickels,et al. β-Cell Function Following Human Islet Transplantation for Type 1 Diabetes , 2005 .
[45] Ames,et al. Islet Transplantation in Seven Patients with Type 1 Diabetes Mellitus Using a Glucocorticoid-Free Immunosuppressive Regimen , 2000 .
[46] M. Field,et al. Inhibition of pancreatic islet beta cell function by tumor necrosis factor is blocked by a soluble tumor necrosis factor receptor. , 1993, Transplantation proceedings.
[47] C. Ricordi,et al. Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. , 1991, The Journal of clinical endocrinology and metabolism.
[48] J. Markmann,et al. The effect of islet cell culture in vitro at 24 degrees C on graft survival and MHC antigen expression. , 1990, Transplantation.
[49] R. Strieter,et al. Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline. , 1988, Biochemical and biophysical research communications.
[50] L. Mandarino,et al. Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. , 1982, The Journal of clinical endocrinology and metabolism.